USFDA approves Novartis' heart failure drug

Novartis announced the US Food and Drug Administration (FDA) approval of a heart failure drug, LCZ696 (sacubitril/valsartan) tablets.

Source: Mumbai News

Related posts:

HSC students welcome 10-minute reading time before paper, say it helps them organize Creativity happens when mind and body are empty or full: Aditi Mangaldas Protests after racial abuse by traffic cop In erstwhile mill district Sewri, towers and tenements coexist, yet struggle to get along